◆ What the Market Isn't Pricing In

ASML poses the hardest kind of investment question: not whether the business is extraordinary — it plainly is — but whether an extraordinary business can be a good investment at an extraordinary price. On the quality of the moat there is little to debate. ASML is the sole maker of the EUV machines without which no advanced chip can be made, a monopoly protected by two decades¹ of irreproducible know-how, an exclusive supply chain, and a compounding technology lead; it earns gross margins above 50% and a return on capital in the forties; it collects a fast-growing, high-margin service annuity on a growing installed base; and it sits at the deepest chokepoint of the artificial-intelligence build-out. This is, by a defensible argument, the widest moat in all of technology. The question the market poses is entirely about price.

And the price is demanding. The stock has re-rated dramatically in the AI boom to over fifty times earnings — around €1,473 a share and roughly €569 billion² in value by September 2026, up enormously over the prior year — a multiple that unambiguously prices in a golden decade: continued AI-driven acceleration, the successful ramp of High-NA, China not deteriorating further, and the company's ambitious 2030 targets (revenue potentially reaching €44–60 billion) being met. The bull case is that these assumptions are not heroic but reasonable, that a true monopoly on the essential input to the most important technology of the age deserves a premium the market has, if anything, been too slow to award, and that the recent guidance raises show demand exceeding even optimistic expectations. On this view, ASML is a rare compounder whose durability the market chronically under-appreciates in the abstract, and fifty times earnings for a monopoly on the future of computing is a fair price for a rare certainty.

The bear case is that the same price leaves no room for the business's two unavoidable realities: cyclicality and geopolitics. The earnings the multiple is applied to are elevated by an AI boom that has never been tested by a downturn, and both the earnings and the multiple would compress together if that boom digested; the China business is shrinking under export controls with the risk of worse; High-NA's ramp has already proven slower than hoped; and a valuation this full simply assumes a great deal of good news that has yet to occur. On this view, ASML is a wonderful business that the market has priced as a flawless one, and the risk is not that the moat fails but that the future, however bright, cannot quite clear the towering bar the price has set.

What the market may be under-appreciating — in either direction — is the sheer singularity of the asset. There is no second ASML, no substitute, no plausible path by which the world makes advanced chips without it for as far ahead as anyone can see; that scarcity may justify a premium no ordinary framework captures, or it may be exactly what has lured the market into paying for perfection. The honest verdict is that ASML is unambiguously one of the great businesses of the age, wrapped in a valuation that requires the future to be nearly as good as the recent past. Whether that is an opportunity or a trap depends less on the moat, which is not in doubt, than on the two things the moat cannot control — the semiconductor cycle and the geopolitics of chips — and on the price one is willing to pay for a certainty that, at ~54× earnings, the market has already largely claimed.